Infleqtion, Inc 8-K/A, filed Aug 18, 2026
Infleqtion, Inc. (INFQ)
8-K/A
2026-08-18
For: 2026-08-12
View Original
Added on
August 19, 2026
About this 8-K/A
Infleqtion, Inc filed this 8-K/A on August 18, 2026, reporting on events of August 12, 2026.
Items reported
- Item 2.02: Financial results
- Item 9.01: Financial statements and exhibits
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________
FORM 8-K/A
___________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 12, 2026
___________________
(Exact name of registrant as specified in its charter)
___________________
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||
(Address of principal executive offices, including zip code)
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
___________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||
share of Common Stock at an exercise price of $11.50 per share | ||||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Explanatory Note
Infleqtion, Inc. (the “Company”) is filing this Current Report on Form 8-K/A (this “Amendment No. 1”) to amend the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on August 12, 2026 (the “Original Form 8-K”) under Items 2.02 and 9.01, which announced its preliminary financial results for the quarter ended June 30, 2026, as presented in a press release dated August 12, 2026, furnished as Exhibit 99.1 thereto (the “Earnings Release”). Since the issuance of the Earnings Release, the Company has identified certain adjustments to its preliminary results included in the Earnings Release related to its recognition of revenue and cost of revenue from certain contracts as well as an error related to revenue recognition and GAAP accounting methodology for the provision of expected losses for certain projects that required certain immaterial adjustments to the prior comparative periods. As a result, the Company is filing this Amendment No. 1 to adjust certain disclosures in the Earnings Release contained in the tables entitled “Condensed Consolidated Balance Sheets” as of June 30, 2026 and December 31, 2025, “Condensed Consolidated Statements of Operations and Comprehensive Loss” for the three and six months ended June 30, 2026 and 2025, and “Condensed Consolidated Statements of Cash Flows” for the six months ended June 30, 2026 and 2025, as well as the corresponding narrative sections in the Earnings Release and the Company’s 2026 revenue outlook. Other than the adjustments discussed in this Amendment No. 1, as described in Item 2.02 herein, all other information disclosed in the Original Form 8-K and Earnings Release remains unchanged. A corrected version of the Earnings Release is furnished herewith as Exhibit 99.1.
Item 2.02 Results of Operations and Financial Condition.
Exhibit 99.1 furnished hereto and incorporated herein by reference updates and supersedes the Earnings Release furnished on the Original Form 8-K with respect to the information presented therein.
The information in this Item 2.02 and in the accompanying Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any of the Company’s filings under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL). | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| INFLEQTION, INC. | ||||||||
Dated: August 17, 2026 | ||||||||
| By: | /s/ Ilan Hart | |||||||
| Name: | Ilan Hart | |||||||
| Title: | Chief Financial Officer | |||||||
Infleqtion Reports Updated Financial Results for Q2 2026 and FY26 Revenue Guidance
Q2 Revenue Increases from $12.6M to $13.5M and FY26 Revenue Guidance Increases from Approximately $43M to Approximately $45.1M to Reflect Shift in Timing of Revenue Recognition for Two Government Contracts
Increases Offset by Corresponding Reduction in Revenue Recognized in 2024 and 2025
No Impact to Cash or Underlying Business Fundamentals
Company Files Form 10-Q for Period Ended June 30, 2026
LOUISVILLE, Colo., August 17, 2026 - Infleqtion, Inc. (NYSE: INFQ) (“Infleqtion” or the “Company”), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission (“SEC”) reporting updated results for the second quarter of 2026, which increases the original results reported in the Company’s press release dated August 12, 2026. The updated results are consistent with the financial information presented in the Company’s Quarterly Report on Form 10-Q, which was filed today with the Securities and Exchange Commission (“SEC”).
Updated Second Quarter 2026 Financial Summary
•Revenue: $13.5 million, up 157% year over year. Revenue growth was 100% organic and entirely from quantum.
•Operating Loss: GAAP operating loss was $29.9 million, compared with $10.4 million in Q2 2025. The increase primarily reflects higher operating expenses as we invest in our strategy, along with higher stock-based compensation. Non-GAAP operating loss was $16.2 million, compared with $7.6 million in Q2 2025.
•2026 Outlook: Updated full-year revenue outlook to approximately $45.1 million, up from $43 million to include non-cash, accounting-based revenue adjustments. There are no changes to the previously provided assumptions underlying the Company’s expectations for its business performance for 2026.
Operating cash flow and cash on the balance sheet remain unchanged from the Company’s August 12 press release.
The Company is providing these updated financial results after identifying an immaterial adjustment related to two government contracts for which revenue was recorded in its prior period financial statements. The Company has also reflected this adjustment in its previously issued financial statements for fiscal years 2024 and 2025, which can be found in its second quarter Form 10-Q.
“We are providing updated Q2 financial results and full year outlook after an accounting adjustment related to two contracts that shifted the timing of revenue recognition between periods with no impact to cash,” said Matt Kinsella, Chief Executive Officer of Infleqtion. “I want to reinforce that Q2 was a record quarter for Infleqtion, we remain on track for 30 logical qubits this year, and the pace of quantum commercialization is accelerating. The quantum market is entering an execution phase, and Infleqtion has spent more than a decade preparing for it.”
As the Company is filing its second quarter Form 10-Q one business day beyond the filing deadline, the Company today also filed a Form 12b-25, Notification of Late Filing, with the SEC. Additional information is available in the Form 10-Q.
Forward Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws, including the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These statements may be identified by words such as “anticipates,” “believes,” “plans,” “seeks,” “will,” “on track” and variations of these words or similar expressions that are intended to identify forward-looking statements. All statements, other than statements of historical facts, including without limitation statements regarding the Company’s expected 2026 revenue, business outlook, customer demand, technology milestones, commercial opportunities, and market momentum are forward looking statements. These statements are based on Infleqtion’s current expectations, assumptions and projections as of the date of this release and are subject to risks and uncertainties that could cause actual results to differ materially and adversely. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Such risks and uncertainties include, without limitation, those related to Infleqtion’s ability to recognize anticipated benefits of its business combination with Churchill Capital Corp X; the implementation, market acceptance, and success of Infleqtion’s business model, growth strategy, and opportunities, and its ability to commercialize its quantum computing technology; the expected benefits of and ability to maintain and enter into new contracts, awards, and other relationships, partnerships, or collaborations with governments or government entities; the potential for quantum computing technology to achieve quantum advantages; the ability of Infleqtion’s products to meet government counterparties’ and customers’ technical requirements and compliance and regulatory needs; Infleqtion’s ability to obtain and maintain intellectual property protection and not infringe on the rights of others; and other risks and uncertainties described in Infleqtion’s Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the U.S. Securities and Exchange Commission. The Company undertakes no obligation to update these forward-looking statements except as required by law.
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures. Infleqtion believes these measures provide investors with additional insight into the underlying performance of the business and, when considered together with the corresponding GAAP measures, assist investors in evaluating Infleqtion’s operating performance and comparing its results across reporting periods. These non-GAAP financial measures should not be considered in isolation or as substitutes for the comparable GAAP measures. In addition, these non-GAAP financial measures may not be computed in the same manner as similarly titled measures used by other companies.
“Non-GAAP Cost of revenue” is defined as cost of revenue expense adjusted to add back, when applicable, stock-based compensation and acquisition and integration costs.
“Non-GAAP R&D” is defined as research and development expense adjusted to add back, when applicable, stock-based compensation and acquisition and integration costs.
“Non-GAAP SG&A” is defined as selling, general and administrative expense adjusted to add back, when applicable, stock-based compensation, acquisition and integration costs, go-public transaction expenses and former executive release payments.
“Non-GAAP Loss from operations” is defined as loss from operations adjusted to add back, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, former executive release payment and impairment of assets and goodwill.
“Non-GAAP Net loss” is defined as net loss adjusted to add back, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, change in fair value of contingent consideration, change in fair value of SAFE liabilities, former executive release payment and impairment of assets and goodwill.
See “Reconciliation of Non-GAAP Financial Measures” in this press release for reconciliations of these non-GAAP measures to the most directly comparable GAAP measures. Management believes that Non-GAAP Cost of revenue, Non-GAAP R&D, Non-GAAP SG&A, Non-GAAP Loss from operations and Non-GAAP Net loss
provide useful information to investors because they facilitate an evaluation of Infleqtion’s underlying operating performance and period-to-period comparability by excluding certain items that management believes do not directly reflect the Company’s core operations or may not be indicative of recurring operating results. Management uses these non-GAAP measures, together with the corresponding GAAP measures, to assess the operating performance of the business.
About Infleqtion
Infleqtion, Inc. (NYSE: INFQ) is a global leader in quantum technology, delivering neutral-atom solutions for quantum computing, networking, sensing and security. Its product portfolio spans quantum computers, quantum optical clocks, RF receivers and inertial sensors, combining high-performance hardware with the Company’s proprietary Superstaq quantum computing software platform. Infleqtion’s systems are used by U.S. and international government and commercial customers across the space, defense, energy, finance and telecommunications sectors. For more information, visit Infleqtion.com or follow Infleqtion on LinkedIn, YouTube and X.
Investor Contact:
Marcus Kupferschmidt
investors@infleqtion.com
Media Contact:
Emily O'Brien
media@infleqtion.com
Infleqtion, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Loss
(Unaudited; in thousands, except share and per share amounts)
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Total revenue | $ | 13,538 | $ | 5,277 | $ | 23,445 | $ | 13,472 | |||||||||||||||
| Total cost of revenue | 11,371 | 4,599 | 18,743 | 9,251 | |||||||||||||||||||
| Gross profit | 2,167 | 678 | 4,702 | 4,221 | |||||||||||||||||||
| Research and development | 12,675 | 5,311 | 22,626 | 10,478 | |||||||||||||||||||
| Selling, general and administrative | 19,818 | 6,250 | 46,138 | 12,034 | |||||||||||||||||||
| Grant income | (468) | (471) | (1,173) | (1,095) | |||||||||||||||||||
| Loss from operations | (29,858) | (10,412) | (62,889) | (17,196) | |||||||||||||||||||
| Other income (expense): | |||||||||||||||||||||||
| Interest income | 5,021 | 719 | 8,223 | 1,075 | |||||||||||||||||||
| Other, net | 142 | 507 | 252 | 1,116 | |||||||||||||||||||
| Total other income, net | 5,163 | 1,226 | 8,475 | 2,191 | |||||||||||||||||||
| Loss before income taxes | (24,695) | (9,186) | (54,414) | (15,005) | |||||||||||||||||||
| Income tax expense (benefit) | — | — | — | — | |||||||||||||||||||
| Net loss | $ | (24,695) | $ | (9,186) | $ | (54,414) | $ | (15,005) | |||||||||||||||
| Other comprehensive (loss) income: | |||||||||||||||||||||||
| Unrealized loss on available-for-sale securities, net | (195) | — | (1,077) | — | |||||||||||||||||||
| Foreign currency translation adjustment | (141) | (22) | (240) | 394 | |||||||||||||||||||
| Total other comprehensive loss | (336) | (22) | (1,317) | 394 | |||||||||||||||||||
| Comprehensive loss | $ | (25,031) | $ | (9,208) | $ | (55,731) | $ | (14,611) | |||||||||||||||
| Net loss per share attributable to common stockholders - basic and diluted | $ | (0.11) | $ | (0.59) | $ | (0.32) | $ | (0.99) | |||||||||||||||
| Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted | 219,743,810 | 15,586,999 | 169,199,551 | 15,164,809 | |||||||||||||||||||
Infleqtion, Inc.
Condensed Consolidated Balance Sheets
(Unaudited; in thousands, except share and per share amounts)
| As of | |||||||||||
| June 30, 2026 (Unaudited) | December 31, 2025 | ||||||||||
| ASSETS | |||||||||||
| CURRENT ASSETS: | |||||||||||
| Cash and cash equivalents | $ | 59,285 | $ | 11,694 | |||||||
| Available-for-sale securities, current | 417,673 | 34,318 | |||||||||
| Accounts receivable | 5,413 | 9,543 | |||||||||
| Unbilled receivables | 3,478 | 2,637 | |||||||||
| Inventories | 5,834 | 4,299 | |||||||||
| Prepaid expenses and other current assets | 8,666 | 10,036 | |||||||||
| Total current assets | $ | 500,349 | $ | 72,527 | |||||||
| Property and equipment, net | 8,684 | 8,674 | |||||||||
| Operating lease right-of-use assets | 13,709 | 4,923 | |||||||||
| Available-for-sale securities, non-current | 104,780 | 17,157 | |||||||||
| Goodwill | 9,315 | 9,315 | |||||||||
| Other assets | 4,617 | 620 | |||||||||
| TOTAL ASSETS | $ | 641,454 | $ | 113,216 | |||||||
| LIABILITIES, CONVERTIBLE REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||||||
| CURRENT LIABILITIES: | |||||||||||
| Accounts payable | 3,650 | $ | 5,644 | ||||||||
| Accrued liabilities | 46,306 | 8,923 | |||||||||
| Contract liabilities | 2,588 | 6,871 | |||||||||
| Current portion of operating lease liabilities | 1,002 | 1,076 | |||||||||
| Deferred consideration payable, current | — | 471 | |||||||||
| Total current liabilities | $ | 53,546 | $ | 22,985 | |||||||
| Operating lease liabilities, net of current portion | 13,525 | 4,074 | |||||||||
| Deferred consideration payable | — | — | |||||||||
| TOTAL LIABILITIES | $ | 67,071 | $ | 27,059 | |||||||
| Convertible Redeemable Preferred Stock: | |||||||||||
| Series Seed convertible redeemable preferred stock; $0.0001 par value per share | — | 6,526 | |||||||||
| Series Seed II convertible redeemable preferred stock; $0.0001 par value per share | — | 10,411 | |||||||||
| Series A convertible redeemable preferred stock; $0.0001 par value per share | — | 36,658 | |||||||||
| Series B convertible redeemable preferred stock; $0.0001 par value per share | — | 112,145 | |||||||||
| Series B-1 convertible redeemable preferred stock; $0.0001 par value per share | — | 32,990 | |||||||||
| Series C convertible redeemable preferred stock; $0.0001 par value per share | — | 71,733 | |||||||||
| Series C-1 convertible redeemable preferred stock; $0.0001 par value per share | — | 26,351 | |||||||||
| Total Convertible Redeemable Preferred Stock | $ | — | $ | 296,814 | |||||||
| Commitments and contingencies (refer to note 9) | |||||||||||
| Stockholders’ Equity (Deficit): | |||||||||||
| Preferred stock: $0.0001 par value per share; 100,000,000 shares authorized; no shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | — | — | |||||||||
| Common stock: $0.0001 par value per share; 1,400,000,000 shares authorized; 224,681,185 and 17,449,020 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | 23 | 2 | |||||||||
| Additional paid-in capital | 862,681 | 21,931 | |||||||||
| Accumulated deficit | (287,910) | (233,496) | |||||||||
| Accumulated other comprehensive income (loss) | (411) | 906 | |||||||||
| Total Stockholders' Equity (Deficit) | $ | 574,383 | $ | (210,657) | |||||||
| Total Liabilities, Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit) | $ | 641,454 | $ | 113,216 | |||||||
Infleqtion, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited; in thousands)
| Six Months Ended June 30, | |||||||||||
| 2026 | 2025 | ||||||||||
| Cash flows from operating activities | |||||||||||
| Net loss | $ | (54,414) | $ | (15,005) | |||||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
| Depreciation and amortization expense | 1,928 | 1,555 | |||||||||
| Stock-based compensation expense | 20,359 | 1,887 | |||||||||
| Change in fair value of contingent obligation | 1,472 | — | |||||||||
| Other non-cash operating adjustments | (2,429) | (807) | |||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable | 4,089 | 1,526 | |||||||||
| Unbilled receivables | (850) | (522) | |||||||||
| Inventories | (1,535) | (1,468) | |||||||||
| Prepaid expenses and other current assets | (3,845) | 671 | |||||||||
| Other assets | (75) | (37) | |||||||||
| Accounts payable | (1,986) | 4,507 | |||||||||
| Accrued liabilities | 35,234 | (2,731) | |||||||||
| Contract liabilities | (4,283) | 994 | |||||||||
| Operating lease right-of-use assets | 711 | 476 | |||||||||
| Operating lease liabilities | (350) | (773) | |||||||||
| Net cash used in operating activities | (5,974) | (9,727) | |||||||||
| Cash flows from investing activities | |||||||||||
| Purchases of available-for-sale securities | (529,743) | — | |||||||||
| Maturities of available-for-sale securities | 60,200 | — | |||||||||
| Purchase of non-marketable equity investment | (3,000) | — | |||||||||
| Purchases of property and equipment | (1,702) | (1,098) | |||||||||
| Net cash used in investing activities | (474,245) | (1,098) | |||||||||
| Cash flows from financing activities | |||||||||||
| Proceeds from issuance of Series C convertible redeemable preferred stock | — | 49,222 | |||||||||
| Proceeds from stock options and warrant exercises | 4,729 | 784 | |||||||||
| Payment of offering costs | (3,306) | — | |||||||||
| Proceeds from Business Combination, net of redemptions | 528,166 | — | |||||||||
| Payment of deferred cash consideration | (475) | (713) | |||||||||
| Net cash provided by financing activities | 529,114 | 49,293 | |||||||||
| Foreign currency translation | (370) | 1,187 | |||||||||
| Net increase in cash and cash equivalents and restricted cash | $ | 48,525 | $ | 39,655 | |||||||
| Cash, cash equivalents and restricted cash at beginning of period | $ | 11,894 | $ | 48,142 | |||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 60,419 | $ | 87,797 | |||||||
Infleqtion, Inc.
Reconciliation of Non-GAAP Financial Measures
(in thousands)
The following is a reconciliation of non-GAAP measures of Infleqtion, Inc. for the three and six ended June 30, 2026 and 2025:
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Cost of revenue | $ | 11,371 | $ | 4,599 | $ | 18,743 | $ | 9,251 | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Stock-based compensation | 1,821 | 109 | 2,838 | 201 | |||||||||||||||||||
| Acquisition and integration costs | — | — | — | — | |||||||||||||||||||
| Non-GAAP Cost of revenue | $ | 9,550 | $ | 4,490 | $ | 15,905 | $ | 9,050 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Research and development expense | $ | 12,675 | $ | 5,311 | $ | 22,626 | $ | 10,478 | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Stock-based compensation | 4,820 | 116 | 7,234 | 188 | |||||||||||||||||||
| Acquisition and integration costs | — | — | — | — | |||||||||||||||||||
| Non-GAAP R&D | $ | 7,855 | $ | 5,195 | $ | 15,392 | $ | 10,290 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Selling, general and administrative expense | $ | 19,818 | $ | 6,250 | $ | 46,138 | $ | 12,034 | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Stock-based compensation | 5,425 | 544 | 10,287 | 1,498 | |||||||||||||||||||
| Acquisition and integration costs | 841 | 2,000 | 1,472 | 2,000 | |||||||||||||||||||
| Go-public transaction expenses | — | — | 11,466 | — | |||||||||||||||||||
| Former executive release payment | 750 | — | 750 | — | |||||||||||||||||||
| Non-GAAP SG&A | $ | 12,802 | $ | 3,706 | $ | 22,163 | $ | 8,536 | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Loss from operations | $ | (29,858) | $ | (10,412) | $ | (62,889) | $ | (17,196) | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Stock-based compensation | 12,066 | 769 | 20,359 | 1,887 | |||||||||||||||||||
| Acquisition and integration costs | 841 | 2,000 | 1,472 | 2,000 | |||||||||||||||||||
| Go-public transaction expenses | — | — | 11,466 | — | |||||||||||||||||||
| Former executive release payment | 750 | — | 750 | — | |||||||||||||||||||
| Non-GAAP Loss from operations | $ | (16,201) | $ | (7,643) | $ | (28,842) | $ | (13,309) | |||||||||||||||
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||||||||||
| Net loss | $ | (24,695) | $ | (9,186) | $ | (54,414) | $ | (15,005) | |||||||||||||||
| Adjustments: | |||||||||||||||||||||||
| Stock-based compensation | 12,066 | 769 | 20,359 | 1,887 | |||||||||||||||||||
| Acquisition and integration costs | 841 | 2,000 | 1,472 | 2,000 | |||||||||||||||||||
| Go-public transaction expenses | — | — | 11,466 | — | |||||||||||||||||||
| Former executive release payment | 750 | — | 750 | — | |||||||||||||||||||
| Non-GAAP Net loss | $ | (11,038) | $ | (6,417) | $ | (20,367) | $ | (11,118) | |||||||||||||||